| Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, D Andes, DK Benjamin Jr, TF Calandra, ... Clinical infectious diseases: an official publication of the Infectious …, 2009 | 3621 | 2009 |
| Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ... Clinical Infectious Diseases 62 (4), e1-e50, 2016 | 3077 | 2016 |
| Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection … DP Kontoyiannis, KA Marr, BJ Park, BD Alexander, EJ Anaissie, TJ Walsh, ... Clinical Infectious Diseases 50 (8), 1091-1100, 2010 | 1419 | 2010 |
| Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) PG Pappas, BD Alexander, DR Andes, S Hadley, CA Kauffman, A Freifeld, ... Clinical Infectious Diseases 50 (8), 1101-1111, 2010 | 1375 | 2010 |
| Clinical practice guideline: adult sinusitis RM Rosenfeld, D Andes, N Bhattacharyya, D Cheung, S Eisenberg, ... Otolaryngology-head and neck surgery 137 (3), S1-S31, 2007 | 1373 | 2007 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 921 | 2020 |
| Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials DR Andes, N Safdar, JW Baddley, G Playford, AC Reboli, JH Rex, ... Clinical infectious diseases 54 (8), 1110-1122, 2012 | 740 | 2012 |
| A recently evolved transcriptional network controls biofilm development in Candida albicans CJ Nobile, EP Fox, JE Nett, TR Sorrells, QM Mitrovich, AD Hernday, ... Cell 148 (1-2), 126-138, 2012 | 619 | 2012 |
| Pharmacokinetics and pharmacodynamics of antibiotics in otitis media WA Craig, D Andes The Pediatric infectious disease journal 15 (3), 255-259, 1996 | 605 | 1996 |
| Inhibition of mutation and combating the evolution of antibiotic resistance RT Cirz, JK Chin, DR Andes, V de Crécy-Lagard, WA Craig, ... PLoS biology 3 (6), e176, 2005 | 600 | 2005 |
| Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo CJ Nobile, DR Andes, JE Nett, FJ Smith Jr, F Yue, QT Phan, ... PLoS pathogens 2 (7), e63, 2006 | 519 | 2006 |
| Antifungal therapeutic drug monitoring: established and emerging indications D Andes, A Pascual, O Marchetti Antimicrobial agents and chemotherapy 53 (1), 24-34, 2009 | 517 | 2009 |
| Animal model pharmacokinetics and pharmacodynamics: a critical review D Andes, WA Craig International journal of antimicrobial agents 19 (4), 261-268, 2002 | 484 | 2002 |
| Voriconazole therapeutic drug monitoring J Smith, N Safdar, V Knasinski, W Simmons, SM Bhavnani, PG Ambrose, ... Antimicrobial agents and chemotherapy 50 (4), 1570-1572, 2006 | 478 | 2006 |
| Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model D Andes, J Nett, P Oschel, R Albrecht, K Marchillo, A Pitula Infection and immunity 72 (10), 6023-6031, 2004 | 432 | 2004 |
| Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance J Nett, L Lincoln, K Marchillo, R Massey, K Holoyda, B Hoff, M VanHandel, ... Antimicrobial agents and chemotherapy 51 (2), 510-520, 2007 | 418 | 2007 |
| Complementary adhesin function in C. albicans biofilm formation CJ Nobile, HA Schneider, JE Nett, DC Sheppard, SG Filler, DR Andes, ... Current biology 18 (14), 1017-1024, 2008 | 398 | 2008 |
| Function of Candida albicans Adhesin Hwp1 in Biofilm Formation CJ Nobile, JE Nett, DR Andes, AP Mitchell Eukaryotic cell 5 (10), 1604-1610, 2006 | 397 | 2006 |
| Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004–2008 MA Pfaller, DR Andes, DJ Diekema, DL Horn, AC Reboli, C Rotstein, ... PloS one 9 (7), e101510, 2014 | 382 | 2014 |
| Pharmacology of systemic antifungal agents ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006 | 382 | 2006 |
